| Product Code: ETC9519214 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Phelan McDermid Syndrome Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Phelan McDermid Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Phelan McDermid Syndrome Market - Industry Life Cycle |
3.4 Suriname Phelan McDermid Syndrome Market - Porter's Five Forces |
3.5 Suriname Phelan McDermid Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Suriname Phelan McDermid Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Suriname Phelan McDermid Syndrome Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Suriname Phelan McDermid Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Phelan-McDermid Syndrome in Suriname |
4.2.2 Growing research and development activities focused on finding treatments for the syndrome |
4.2.3 Supportive government policies and funding for rare disease research in Suriname |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Suriname |
4.3.2 High cost of treatment and lack of affordable options for patients with Phelan-McDermid Syndrome |
4.3.3 Lack of specialized healthcare professionals with expertise in managing the syndrome in Suriname |
5 Suriname Phelan McDermid Syndrome Market Trends |
6 Suriname Phelan McDermid Syndrome Market, By Types |
6.1 Suriname Phelan McDermid Syndrome Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Chromosomal microarray, 2021- 2031F |
6.1.4 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Karyotyping, 2021- 2031F |
6.1.5 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By DNA sequencing, 2021- 2031F |
6.2 Suriname Phelan McDermid Syndrome Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Applied behavior analysis, 2021- 2031F |
6.2.3 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Occupational therapy, 2021- 2031F |
6.2.4 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Physical therapy, 2021- 2031F |
6.2.5 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Phelan McDermid Syndrome Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.3.4 Suriname Phelan McDermid Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Phelan McDermid Syndrome Market Import-Export Trade Statistics |
7.1 Suriname Phelan McDermid Syndrome Market Export to Major Countries |
7.2 Suriname Phelan McDermid Syndrome Market Imports from Major Countries |
8 Suriname Phelan McDermid Syndrome Market Key Performance Indicators |
8.1 Number of clinical trials for Phelan-McDermid Syndrome conducted in Suriname |
8.2 Adoption rate of new treatment options for the syndrome in Suriname |
8.3 Patient satisfaction and quality of life improvements reported by individuals with Phelan-McDermid Syndrome in Suriname |
9 Suriname Phelan McDermid Syndrome Market - Opportunity Assessment |
9.1 Suriname Phelan McDermid Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Suriname Phelan McDermid Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Suriname Phelan McDermid Syndrome Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Suriname Phelan McDermid Syndrome Market - Competitive Landscape |
10.1 Suriname Phelan McDermid Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Suriname Phelan McDermid Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here